Reports FY24 revenue $492M, consensus $455.53M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALVO:
- Alvotech Appoints New Chief Strategy Officer to Strengthen Market Position
- Alvotech Achieves Record 2024 Financial Results and Expands Biosimilar Pipeline
- Alvotech appoints Balaji Prasad as chief strategy officer
- Alvotech’s Biosimilar to Xolair Gains UK Regulatory Acceptance
- Alvotech Expands with Acquisition of Xbrane’s R&D Operations